image
KalVista Pharmaceuticals, Inc. KALV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.49
-3.16 %
$ 462 M
Market Cap
-2.74
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-04-30 0.00% -69.19% -26.67%
Annual Report FY 10-K 2023-04-30 0.00% -9.26% -14.76%
Annual Report FY 10-K 2022-04-30 0.00% -53.98% -66.80%
Annual Report FY 10-K 2021-04-30 0.00% -52.82% -42.90%
Annual Report FY 10-K 2020-04-30 -21.31% -39.87% -35.93%
Annual Report FY 10-K 2019-04-30 92.13% -31.71% -59.42%
Annual Report FY 10-K 2018-04-30 458.11% 15.04% 16.27%
Annual Report FY 10-K 2017-04-30 -29.49% -62.67% -47.15%
Annual Report FY 10-K 2016-04-30 18.24% -58.26% -87.67%
Annual Report FY 10-K 2015-04-30 334.70% -27.26% -55.08%
Annual Report FY 10-K 2013-12-31 -73.02% -176.57% -184.56%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2024-07-31 0.00% -59.75% -51.98%
Quarterly Report Q4 8-K 2024-04-30 0.00% -11.53% -52.72%
Quarterly Report Q3 8-K 2024-01-31 0.00% -102.54% -23.03%
Quarterly Report Q2 8-K 2023-10-31 0.00% -49.47% -14.92%
Quarterly Report Q1 8-K 2023-07-31 0.00% -9.87% -10.55%
Quarterly Report Q4 8-K 2023-04-30 0.00% -80.70% -18.34%
Quarterly Report Q3 8-K 2023-01-31 0.00% 36.21% -0.98%
Quarterly Report Q2 8-K 2022-10-31 0.00% 5.86% -9.66%
Quarterly Report Q1 8-K 2022-07-31 0.00% -43.04% -34.84%
Quarterly Report Q4 8-K 2022-04-30 0.00% -48.12% -48.60%
Quarterly Report Q3 8-K 2022-01-31 0.00% -123.60% -110.82%
Quarterly Report Q2 8-K 2021-10-31 0.00% -88.47% -84.67%
Quarterly Report Q1 8-K 2021-07-31 0.00% -48.96% -35.12%
Quarterly Report Q4 8-K 2021-04-30 231.85% -127.14% -101.43%
Quarterly Report Q3 8-K 2021-01-31 0.00% -8.15% 0.53%
Quarterly Report Q2 8-K 2020-10-31 0.00% -76.62% -37.59%
Quarterly Report Q1 8-K 2020-07-31 0.00% -47.37% -51.01%
Quarterly Report Q4 8-K 2020-04-30 30.69% 22.77% 20.45%
Quarterly Report Q3 8-K 2020-01-31 -59.46% -134.86% -91.05%
Quarterly Report Q2 8-K 2019-10-31 -29.90% -78.66% -89.84%
Quarterly Report Q1 8-K 2019-07-31 -9.39% -45.88% -36.45%
Quarterly Report Q4 8-K 2019-04-30 -39.55% -1197.72% -279.25%
Quarterly Report Q3 8-K 2019-01-31 66.88% 24.42% -53.24%
Quarterly Report Q2 8-K 2018-10-31 396.18% 33.73% 17.58%
Quarterly Report Q1 8-K 2018-07-31 3772.92% -2.07% -28.53%
Quarterly Report Q4 8-K 2018-04-30 4145.61% 84.36% 41.62%
Quarterly Report Q3 8-K 2018-01-31 839.92% 31.53% 46.46%
Quarterly Report Q2 8-K 2017-10-31 0.00% 0.00% -146.86%
Quarterly Report Q1 8-K 2017-07-31 1271.43% -108.37% -126.74%
Quarterly Report Q4 8-K 2017-04-30 1528.57% 36.40% 22.09%
Quarterly Report Q3 8-K 2017-01-31 3000.00% -35.08% -45.75%
Quarterly Report Q2 8-K 2016-09-30 0.00% 100.00% 50.91%
Quarterly Report Q1 8-K 2016-06-30 0.00% 73.76% 57.56%
Quarterly Report Q4 8-K 2016-03-31 0.00% -27.45% -33.20%
Quarterly Report Q3 8-K 2015-12-31 0.00% -20.05% -45.90%
Quarterly Report Q2 8-K 2015-09-30 -30.00% -24.93% -37.30%
Quarterly Report Q1 8-K 2015-06-30 40.00% -242.01% -132.64%
Quarterly Report Q4 8-K 2015-03-31 16.67% -157.27% -164.06%
Quarterly Report Q3 8-K 2014-12-31 -97.99% -290.56% -251.47%
Quarterly Report Q2 8-K 2014-09-30 0.00% 82.05% 83.97%
Quarterly Report Q1 8-K 2014-06-30 -99.99% 83.64% 0.00%
Quarterly Report Q4 8-K 2014-03-31 0.00% 90.54% 91.29%
Quarterly Report Q3 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2001-10-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2001-07-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2001-01-31 0.00% 0.00% 0.00%